Joyce Meghan V. sold $1.3M of GH
Joyce Meghan V. sold 10,000 shares of Guardant Health, Inc. (GH) at an average of $126.98 ($126.52–$129.31, $1.27M total) across 4 trades on 2026-06-03 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosed sale may prompt short‑term traders to watch GH for potential price dip, though the pre‑arranged nature tempers significance.
Market read
Routine insider sale with modest size; limited impact on broader market.
What to watch
The 10b5-1 plan indicates the sale was pre‑scheduled, reducing the informational content of the transaction.
Background
SEC Form 4 filing discloses insider transactions; such filings are primary sources for insider activity.
Ticker impact
Director Joyce Meghan V. sold 10,000 shares for $1.27M via a 10b5-1 plan, reducing her stake to 11,183 shares.
likely slight downward pressure as investors price in the insider sell.
Director-level insider sold a sizable block at market price; such sales often prompt short-term sell‑offs.
Market effects
Minimal; Guardant operates in liquid biopsy sector, but a single insider sale does not shift sector outlook.
None; the filing is company‑specific.
Low; no broader market effect.
Counterpoint
The sale could be purely portfolio rebalancing under a pre‑arranged plan, not a negative signal.
Key entities
- companyGuardant Health, Inc.
NASDAQ‑listed liquid biopsy company.
- personJoyce Meghan V.
Director of Guardant Health.
